The real deal

In their latest briefing Cellestis describe how useful the Diel meta-analysis is as a marketing tool;

This definitive analysis of all relevant papers has been highlighted to our customers by our sales & marketing team, and those of our commercial partners

It is important to be able to independently verify the performance data

When Clinicians have a test result they want to know how confident they can be in the result in various settings for particular patients.

The meta-analysis also firmly puts to rest various "opinions" floating around

• Highlights the superior performance of QFT over both TST and T-Spot.TB.
• Clarifies the much lower specificity of T-Spot.TB - previously promoted by the manufacturer as 99.9%!
• Demonstrates that the rate of Indeterminate results is lowest with QFT.
• Highlights how medically inappropriate the TST really is, and how valuable QFT is for TB control.